Polyphor, Boehringer form pact for macrocycle drug discovery
This article was originally published in Scrip
Executive Summary
The Swiss company Polyphor Ltd and Boehringer Ingelheim have agreed to partner and use Polyphor's proprietary MacroFinder drug discovery technology to identify macrocyclic molecules against undisclosed targets selected by Boehringer.